Showing results (31-40 of 2,455) with videos related to
Sort By:
Pageof 246
Therapie|December 21, 2013
[Adverse effects of sulfasalazine: discussion of mechanism and role of sulfonamide structure]Rim Atheymen, Hanen Affes, Kamilia Ksouda, et al.Therapie|November 1, 1989
[Potassium channel activators: from pharmacology to therapeutics]J F Giudicelli, C RicherTherapie|April 16, 2016
What specifications for a centre or network of excellence in clinical research?Vincent Diebolt, Marie Lang, Frédérique Thoby, et al.Therapie|April 16, 2016
Organisational impact: Definition and assessment methods for medical devicesChristophe Roussel, Cédric Carbonneil, Antoine Audry, et al.Therapie|April 16, 2016
The history of pharmacovigilanceJacques Caron, Michaël Rochoy, Louise Gaboriau, et al.Therapie|April 16, 2016
French pharmacovigilance: Missions, organization and perspectivesThierry VialTherapie|April 16, 2016
Pharmacovigilance in Europe: Place of the Pharmacovigilance Risk Assessment Committee (PRAC) in organisation and decisional processesMarie-Laure Laroche, Arnaud Batz, Hélène Géniaux, et al.Therapie|April 16, 2016
Measuring the preventability of adverse drug reactions in France: A 2015 overviewPascale Olivier-AbbalTherapie|April 16, 2016
Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?Haleh Bagheri, Isabelle Lacroix, Emmanuelle Guitton, et al.Therapie|January 1, 1989
[Delayed-action theophylline versus placebo on the ventilatory function of stable asthmatic patients. Study in relation to circadian rhythm]J Vergeret, A Taytard, J J Douvier, et al.Pageof 246